Clinical Trials

NCT06904066 | RECRUITING | PHASE1
86 participants

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-14
Start Date:
2026-08-19
Completion:
2029-04-30
Conditions
  • Malignancy, Hematologic
  • Neoplasms, Hematologic
  • Neoplasms, Hematopoietic
  • Blood Cancer
  • Hematological Neoplasms
  • Hematopoietic Malignancies
  • Dysmyelopoietic Syndromes
  • Hematopoetic Myelodysplasia
  • Myeloid Leukemia, Acute
  • Nonlymphoblastic Leukemia, Acute
  • Leukemia, Lymphocytic, Acute
Interventions
  • DRUG
  • BIOLOGICAL
  • DEVICE
No Results Yet
NCT06903208 | RECRUITING | NA
10 participants

RFA for Superficial Lipomas

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-14
Start Date:
2025-04-02
Completion:
2027-07-31
Conditions
  • Lipoma
Interventions
  • DEVICE
No Results Yet
NCT06890338 | RECRUITING | PHASE2
140 participants

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-14
Start Date:
2025-11-21
Completion:
2030-02-28
Conditions
  • Epithelial Ovarian Cancer
  • Fallopian Tube Cancer
  • Primary Peritoneal Cancer
  • Neoadjuvant
Interventions
  • DRUG
No Results Yet
NCT06860594 | RECRUITING | PHASE1
30 participants

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-14
Start Date:
2025-07-30
Completion:
2027-06-30
Conditions
  • Astrocytoma, IDH-Mutant, Grade 2
  • Recurrent Adult Diffuse Hemispheric Glioma, H3 G34-Mutant
  • Recurrent Adult Diffuse Midline Glioma, H3 K27-Mutant
  • Recurrent Astrocytoma, IDH-Mutant
  • Recurrent Astrocytoma, IDH-Mutant, Grade 3
  • Recurrent Astrocytoma, IDH-Mutant, Grade 4
  • Recurrent Glioblastoma, IDH-Wildtype
Interventions
  • PROCEDURE
  • RADIATION
  • DRUG
No Results Yet
NCT06824467 | RECRUITING | PHASE3
770 participants

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-14
Start Date:
2025-04-09
Completion:
2029-04-27
Conditions
  • Ovarian Cancer
  • Fallopian Tube Cancer
  • Primary Peritoneal Cancer
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT06812533 | RECRUITING | NA
350 participants

Alleviant ALLAY-HFrEF Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-14
Start Date:
2025-03-10
Completion:
2028-12-31
Conditions
  • Heart Failure
Interventions
  • DEVICE
  • OTHER
No Results Yet
NCT06809907 | COMPLETED
1600 participants

Kintsugi Voice Device Pivotal Study

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-14
Start Date:
2025-03-27
Completion:
2026-02-28
Conditions
  • Depression
  • Depression Moderate
  • Depression Severe
  • Depression Mild
Interventions
  • DEVICE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page